Aclaris Therapeutics Inc — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Aclaris Therapeutics Inc (EIN 46-0571712) is a plan sponsor located in Wayne, PA with 1 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN
46-0571712
Location
Wayne, PA
Loaded plans
2
Latest filing year
2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY)
$12,430,834
Total reported liabilities (EOY)
$0
Total reported net assets (EOY)
$12,430,834

Contributions & income

Employer contributions
$707,520
Participant contributions
$1,712,221
Total income / additions
$4,675,015

Expenses & distributions

Benefits paid / distributions
$1,553,142
Total expenses
$1,590,228
Net increase / (decrease)
$3,084,787

Coverage

Total reported participants
254
Plans with financial statements
1
Plans with provider compensation
1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Aclaris Therapeutics Inc plans by reported end-of-year assets
PlanPlan #ParticipantsReported assets (EOY)Year
Aclaris Therapeutics Inc 401(K) Plan001154$12,430,8342023
Aclaris Therapeutics, Inc. Benefits And Welfare Plan501100not reported in the loaded dataset2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Aclaris Therapeutics Inc
YearPlanParticipantsSchedulesFiling
2023Aclaris Therapeutics, Inc. Benefits And Welfare Plan10020240718152628NAL0003296675001
2023Aclaris Therapeutics Inc 401(K) Plan154H, C20241014091723NAL0025804065001

Related Form 5500 pages